{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:33:33Z","timestamp":1777376013348,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ejphar.2014.06.007","type":"journal-article","created":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T20:16:53Z","timestamp":1403295413000},"page":"697-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Generalized estimating equation model and long-term exposure effect of antipsychotics on SH-SY5Y cells against oxidative stressors"],"prefix":"10.1016","volume":"740","author":[{"given":"Ming-Chang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Po","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"For-Wey","family":"Lung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.06.007_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000202823","article-title":"Potential effect of olanzapine on total antioxidant status and lipid peroxidation in schizophrenic patients","volume":"59","author":"Al-Chalabi","year":"2009","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ejphar.2014.06.007_bib2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.10290","article-title":"Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal","volume":"69","author":"Bai","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2014.06.007_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2008.07.021","article-title":"Paliperidone as a mood stabilizer: a pre-frontal cortex synaptoneurosomal proteomics comparison with lithium and valproic acid after chronic treatment reveals similarities in protein expression","volume":"1233","author":"Corena-McLeod","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2014.06.007_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clinthera.2008.02.011","article-title":"Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia","volume":"30","author":"Fowler","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2014.06.007_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2009.05.063","article-title":"Clozapine protects PC-12 cells from death due to oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism involving inhibition of extracellular signal-regulated kinase phosphorylation","volume":"1283","author":"Magliaro","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2014.06.007_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1017\/S1461145707008401","article-title":"Oxidative stress in psychiatric disorders: evidence base and therapeutic implications","volume":"11","author":"Ng","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2014.06.007_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00004714-200102000-00004","article-title":"Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial","volume":"21","author":"Perry","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.06.007_bib8","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1046\/j.1460-9568.2003.02590.x","article-title":"The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis","volume":"17","author":"Qing","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.06.007_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-9964(02)00407-3","article-title":"Reduced plasma antioxidants in first-episode patients with schizophrenia","volume":"62","author":"Reddy","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2014.06.007_bib10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jpsychires.2008.11.005","article-title":"Impact of haloperidol and quetiapine on the expression of genes encoding antioxidant enzymes in human neuroblastoma SH-SY5Y cells","volume":"43","author":"Schmidt","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejphar.2014.06.007_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/0269881108096506","article-title":"Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro","volume":"24","author":"Schmidt","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.06.007_bib12","first-page":"303","article-title":"Variability in endotoxin exposure levels and consequences for exposure assessment","volume":"52","author":"Spaan","year":"2008","journal-title":"Ann. Occup. Hyg."},{"key":"10.1016\/j.ejphar.2014.06.007_bib13","first-page":"343","article-title":"A meta-analytic approach for characterizing the within-worker and between-worker sources of variation in occupational exposure","volume":"50","author":"Symanski","year":"2006","journal-title":"Ann. Occup. Hyg."},{"key":"10.1016\/j.ejphar.2014.06.007_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00213-011-2291-7","article-title":"Neuroprotection of paliperidone on SH-SY5Y cells against \u03b2-amyloid peptide(25-35), N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death","volume":"217","author":"Yang","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.06.007_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometrics"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400449X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400449X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T17:18:38Z","timestamp":1764263918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991400449X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":15,"alternative-id":["S001429991400449X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.06.007","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generalized estimating equation model and long-term exposure effect of antipsychotics on SH-SY5Y cells against oxidative stressors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}